Journal
JOURNAL OF GENE MEDICINE
Volume 14, Issue 4, Pages 272-278Publisher
WILEY
DOI: 10.1002/jgm.2618
Keywords
gene therapy; foot ulcer; minicircle DNA; nonviral gene delivery carrier; PAM-RG4; VEGF; wound healing
Categories
Funding
- Ministry of Education, Science and Technology in the Republic of Korea [20110018684]
- National Research Foundation of Korea (NRF)
- Korea government (MEST) [2011K000818]
- Seoul Science Fellowship
Ask authors/readers for more resources
Background The development of an efficient method to improve the wound healing process is urgently required for diabetic patients suffering a threat of limb amputations. Various growth factors have been proposed for treatment; however, more research still has to be carried out to maintain their curative effect. In the present study, we describe a simple nonviral gene therapy method for improving wound healing. Methods Minicircle plasmid DNA encoding vascular endothelial growth factor (VEGF) was combined with an arginine-grafted cationic dendrimer, PAM-RG4. The formed complexes were injected subcutaneously into the skin wounds of diabetic mice. Results Actively proliferating cells in wound tissue were efficiently transfected, resulting in a high level of VEGF expression. Within 6 days after injection, skin wounds in the diabetic mice were generally healed and displayed a well-ordered dermal structure, which was confirmed by histological staining. Conclusions This simple and effective gene therapy method may represent a powerful tool for the treatment of diabetic foot ulcers and other diseases that are refractory to treatment. Copyright (C) 2012 John Wiley & Sons, Ltd.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available